New Target (Shanghai) Molecular Medical Technology Co., Ltd., established on 2005-09-27, Business scope includes molecular medical technology,Technology development in the field of data analysis software,technical consulting,technology transfer,Technical Services,Engaged in the import and export of goods and technology. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Abbott Molecular is an emerging leader in molecular diagnostics and the analysis of DNA, RNA, and proteins at the molecular level. They are committed to exploring new clinical frontiers through the development and delivery of system and assay solutions that are designed to provide earlier disease diagnosis, selection of appropriate therapies and monitoring of disease recurrence. Their expanding portfolio brings multiples technologies that enable fast, accurate results. Their state of the art research and manufacturing facilities have hundreds of scientists who are dedicated to producing quality and reliable products. Over 350 products are available in the areas of infectious disease, oncology, genetics, and automation. Some of these products include: the m2000 system which has an extensive assay menu in infectious disease featuring Abbott RealTime technology with a broad range of assays, PathVysion HER-2 DNA Probe Kit for breast cancer, ALK Break Apart FISH Probe Kit, and UroVysion Bladder Cancer Kit are important applications of the FISH technology.

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following business segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Medical Devices segment includes electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

deCODE genetics, Inc. (Icelandic: Íslensk erfðagreining) is a biopharmaceutical company based in Reykjavík, Iceland. The company was founded in 1996 by Kári Stefánsson to identify human genes associated with common diseases using population studies, and apply the knowledge gained to guide the development of candidate drugs. The company isolated genes believed to be involved in cardiovascular disease, cancer and schizophrenia, among other diseases (the company's research concerning the latter is said to represent the first time a gene has been identified by two independent studies to be associated with schizophrenia).

D&P Biotech, Inc. is engaged in research and development of molecular diagnostics. The company was founded on March 3, 2006 and is headquartered in Seoul, South Korea.

Shenzhen Ruio Kangchen Biotechnology Co., Ltd., established on 2015-06-08, Business scope includes general business items:biotechnology development;Operating import and export business(law,Administrative regulations,Except for items prohibited by the State Council,Restricted projects must obtain a license before operating);computer software,Technical development of information system software;Trade Brokers & Agents;Health and wellness management consulting(Does not include medical industry);Technical Development of Physical Examination Information System Software;Sales of Class I Medical Devices;Domestic Trade(Does not contain franchise,monopoly,Specially Controlled Commodities).,The licensing program is:Intermediary services for private entry and exit;Commercial Internet Information Services;Class II,Sales of Class III Medical Devices;Healthy food,sales of medicines.

Xu Zhou Ai Wan Yi Xue Jian Yan Shi Yan Shi You Xian Gong Si, established on 2022-03-10, Business scope includes licensed projects:Inspection and testing service;medical service;Drug Clinical Trial Services;Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business;Forensic identification service(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Medical Research and Experimental Development;Development of Human Gene Diagnosis and Therapy Technology;R&D and application of cell technology;Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Manufacturing of experimental analysis instruments;Experimental analysis instrument sales;Engineering and Technology Research and Experimental Development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Computer System Services(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Hunan Baibo Gene Technology Co., Ltd., established on 2015-04-07, Business scope includes medical research and experimental development;Medical Device Technology Development;Class I medical device,Class II medical device,Class II:6840Clinical Laboratory Analytical Instruments,Class II:6840In vitro diagnostic reagents,Class III Medical Devices,Research and development of biological products;Medical device technical consultation,communication service;Medical device technology transfer service;computer technology development,Technical Services;Class I medical device,Class II medical device,Class III Medical Devices,Class II:6840In vitro diagnostic reagents,Class II:6840Clinical Laboratory Analytical Instruments,production of biological products;Class I medical device,Class II medical device,Class III Medical Devices,Class II:6840Clinical Laboratory Analytical Instruments,Class II:6840In vitro diagnostic reagents,Biological product,computer software,Sales of medical laboratory equipment and appliances;Chemical Reagent and Auxiliary Manufacturing(Free of hazardous and monitored chemicals).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Tianjin Mailuo Medical Laboratory Co., Ltd., established on 2016-03-11, Business scope includes licensed projects:Inspection and testing service;medical service.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments).General project:Medical Research and Experimental Development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Natural science research and experimental development.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).

Ningbo Meijing Medical Technology Co., Ltd., established on 2012-03-22, Business scope includes medical technology testing services;Class I medical device rental and maintenance;Research and development of medical technology and medical devices;Biological experiment reagent(Not for clinical use),Sales of biological laboratory consumables;Class I medical device,Production and sales of Class II medical devices;Software and hardware development and sales;Medical equipment rental,Maintenance service,Technical Advisory Services;Self-operated or agent import and export business of various goods and technologies,Except for goods and technologies prohibited or restricted by the state.(The branch office is located in:Juxian Road, High-tech Zone, Ningbo1299No028The area on the second floor of the factory building)(operating under a license,Not to operate until a license is obtained)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Wuhan Saiyunbo Biotechnology Co., Ltd., established on 2016-06-21, The scope of business includes the field of biotechnology,stem cell,Biological product,cosmetic,Technology development in the field of information technology,technical consulting,technology transfer;Laboratory equipment and accessories,chemical reagent(Does not contain dangerous goods),cosmetic,Wholesale and retail of computer software and auxiliary equipment;Import and export,Technology Import and Export,Agent import and export(Does not contain goods or technologies that are prohibited or restricted from import and export by the state).(Projects subject to approval by law,Business activities can only be carried out after approval by relevant departments)

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

Oncotherapy science (OTS) is“ to deliver cancer therapeutics and treatments with higher efficacy and fewer side effects to patients suffering from cancer as soon as possible, and to overcome the fight against cancer. Was established with the aim of OTS brought Professor Genomix (Science that handles genetic information systematically) as a pioneer in the medical field with Prof. Atsushi Nakamura (Director, Cancer Precision Medical Research Center, Institute of Cancer, Professor Emeritus, The University of Tokyo, Professor Emeritus of Chicago University) Joint research to identify target molecules suitable for cancer drug development based on comprehensive gene expression analysis, and promote research and development of small molecule drugs, cancer peptide vaccines and antibody drugs for those targets.

Beijing Nuosai Genome Research Center Co., Ltd., established on 1998-09-24, The scope of business includes the development of genetic engineering and bioengineering technologies and products,to develop,Sales;technology development,technology transfer,technical consulting,Technical Services,Technical testing;Biological and genetic analysis instruments,information equipment,Development of Medical Devices,to develop,Sales;Information Consulting;Self-operated and agent import and export of various commodities and technologies,Except for the goods and technologies that the state restricts the company to operate or prohibits the import and export of;software development;Conference Services;selling computers,Software and Auxiliary Equipment;health management,Health Advisory(Except for medical treatment activities subject to approval);Sales of medical devicesIkind,medical instrumentsIIkind;production of medical devicesIkind;Natural science research and experimental development;Medical Research and Experimental Development;Sales No.IIIclass of medical devices;Production No.IIkind,No.IIIclass of medical devices;medical examination medical service.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Production No.IIkind,No.IIIclass of medical devices,Sales No.IIIclass of medical devices,Medical testing and medical services and items subject to approval according to law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Suzhou Innova Pharmaceutical Technology Consulting Co., Ltd., established on 2015-07-08, Business scope includes medical science and technology consulting,Business Management Consulting,Enterprise Marketing Planning,Enterprise merger and reorganization program planning.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Founded in beautiful Guangzhou in 2014, Top is a wholly-owned subsidiary of Top Medical Group. Top's gene has always been committed to patient-centered and improving human health. With the " gene + referral " integrated service, the combination of " scientific research + clinical " application, and the " gene + cell " dual-engine drive model, the clinical application of precision medicine is promoted, thus driving the rapid development of science and technology in the field of genes and cells.

The United States Department of Veterans Affairs (VA) is a federal Cabinet-level agency that provides near-comprehensive healthcare services to eligible military veterans at VA medical centers and outpatient clinics located throughout the country; several non-healthcare benefits including disability compensation, vocational rehabilitation, education assistance, home loans, and life insurance; and provides burial and memorial benefits to eligible veterans and family members at 135 national cemeteries.

Shanghai Chest Hospital is a company headquartered in China ultimately controlled by the Government of China. The firm specializes in treating cadio-vascular system, lungs, esophagus, trachea and mediastinum.